• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers
    FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

    FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

    This week, Adaptimmune clinched gold when it secured the first-ever US Food and Drug Administration (FDA) approval for a T-cell...

    Impressions : 1168

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.